Fujifilm and the Center for Advanced Biological Innovation and Manufacturing Announce $76M in Funding for Manufacturing and Innovation Center

SourcePR Newswire
Date Published01/14/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Fujifilm Diosynth Biotechnologies
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):40
Year reshoring announced:2019
Year reshoring implemented or to be implemented:2022
Domestically, the work will be done:In-house
Capital investment ($):76
Country(ies) from which reshored:Japan
City reshored to:Waterton
State(s) reshored to:MA
If relevant, work nearshored to:-
Product(s) reshoredtherapeutics
What domestic positive factors made reshoring more attractive?, essential product supply
Find Reshoring Articles